Are you Dr. Li?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 40 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
333 Providence Hwy
Boston Biomedical, Inc.
Norwood, MA 02062Phone+1 781-278-0846Fax+1 781-762-9863- Is this information wrong?
Summary
- Dr. Chiang Li, MD is a gastroenterologist in Norwood, Massachusetts. He is affiliated with Beth Israel Deaconess Medical Center and is a Lecturer on Medicine at Beth Israel Deaconess Medical Center.
Education & Training
- Beth Israel Deaconess Medical CenterFellowship, Gastroenterology, 2001 - 2004
- Brigham and Women's HospitalResidency, Internal Medicine, 1998 - 2001
- Harvard Medical SchoolClass of 1998
Publications & Presentations
PubMed
- 1 citationsRandomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel ± Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.Manish A Shah, Kohei Shitara, Florian Lordick, Yung-Jue Bang, Niall C Tebbutt, Jean-Phillippe Metges, Kei Muro, Keun-Wook Lee, Lin Shen, Sergei Tjulandin, John L Hays,...> ;Clinical Cancer Research. 2022 Jul 14
- Randomized, double-blind, placebo-controlled phase 3 study of paclitaxel {plus minus} napabucasin in pretreated advanced gastric or gastroesophageal junction adenocarc...Manish A Shah, Kohei Shitara, Florian Lordick, Yung-Jue Bang, Niall C Tebbutt, Jean-Phillippe Metges, Kei Muro, Keun-Wook Lee, Lin Shen, Sergei Tjulandin, John L Hays,...> ;Clinical cancer research : an official journal of the American Association for Cancer Research. 2022 May 26
- Synthetic Biology Medicine and Bacteria-Based Cancer Therapeutics.Jaehyung Lee, Andrew C. Keates, Chiang J. Li> ;Methods in Molecular Biology. 2021 Jan 1
- Join now to see all
Press Mentions
- The End of Toxic Chemo and RadiationDecember 23rd, 2019
- Boston Biomedical Presents Clinical Data on First-in-Class Cancer Stemness Inhibitor Napabucasin at 2017 ASCO GI SymposiumJanuary 21st, 2017
- Boston Biomedical Presents Clinical Data on First-in-Class Cancer Stemness Inhibitor Napabucasin at 2017 ASCO GI SymposiumJanuary 21st, 2017
- Join now to see all
Hospital Affiliations
- Beth Israel Deaconess Medical CenterBoston, Massachusetts